Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, Room ZH 3A74, de Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.
Department of Infectious Diseases, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):1843-1850. doi: 10.1007/s10096-021-04234-1. Epub 2021 Apr 1.
This study evaluated the effectiveness of selective digestive tract decontamination (SDD) application three times daily (t.i.d.) compared to the standard four times daily (q.i.d.). Retrospective equivalence (combined non-inferiority and non-superiority design) study with a before-and-after design on a tertiary ICU in which the SDD frequency was reduced from q.i.d. to t.i.d. All patients with ICU admissions ≥72h and with ≥2 surveillance cultures collected on different dates were included in this study. We compared successful decontamination of Gram-negative bacteria (GNB). Furthermore, time to decontamination, ICU-acquired GNB bacteraemia and 28-day mortality were compared between the two groups. In total 1958 ICU admissions (1236 q.i.d., 722 t.i.d). Decontamination was achieved during the first week of admission in 77% and 76% of patients receiving SDD q.i.d and t.i.d., respectively. Successful decontamination within 14 days (without consecutive acquisition of Gram-negative bacteria) was achieved in 69.3% of the admissions with q.i.d. versus 66.8% in t.i.d. SDD (p-value = 0.2519). The proportions of successful decontamination of GNB were equivalent in both groups (-0.025, 98% CI: -0.087; 0.037). There was no significant difference in time to decontamination between the two regimens (log-rank test p-value = 0.55). Incidence (episodes/1000 days) of ICU-acquired GNB bacteraemia was 0.9 in both groups, and OR for death at day 28 in the t.i.d. group compared to the q.i.d. group was 0.99 (95% confidence interval, 0.80-1.21). This study shows that a t.i.d. application regimen achieves similar outcomes to the standard q.i.d. regime, for both microbiological and clinical outcome measures.
这项研究评估了每日三次(tid)而非标准每日四次(qid)的选择性消化道去污染(SDD)应用的效果。这是一项回顾性等效性(联合非劣效性和非优越性设计)研究,采用前后设计,在一家三级 ICU 中,将 SDD 频率从 qid 降低至 tid。所有 ICU 入住时间≥72h 且≥2 次不同日期采集的监测培养物的患者均纳入本研究。我们比较了两组患者革兰氏阴性菌(GNB)去污染的成功率。此外,还比较了两组患者去污染时间、ICU 获得性 GNB 菌血症和 28 天死亡率。共纳入 1958 例 ICU 入住患者(qid:1236 例,tid:722 例)。接受 qid 和 tid SDD 的患者,分别有 77%和 76%在入院的第一周内实现去污染。在 qid 组中,70.3%的患者在 14 天内(无连续获得革兰氏阴性菌)实现了成功去污染,tid 组中这一比例为 66.8%(p 值=0.2519)。两组患者的 GNB 去污染成功率相当(-0.025,98%CI:-0.087;0.037)。两组方案之间去污染时间无显著差异(对数秩检验 p 值=0.55)。两组 ICU 获得性 GNB 菌血症的发生率(每 1000 天的发病例数)均为 0.9,tid 组与 qid 组相比,第 28 天的死亡率的 OR 为 0.99(95%置信区间:0.80-1.21)。本研究表明,tid 应用方案在微生物学和临床结局方面均能达到与标准 qid 方案相似的效果。